Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - Apyx Medical Corpexhibit99.htm
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
______________________
 
FORM 8-K
 
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
August 5, 2014
Date of Report (Date of earliest event reported)
 
BOVIE MEDICAL CORPORATION
(Exact name of registrant as specified in its Charter)
 
 
 
Delaware
 
012183
 
11-2644611
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
 
5115 Ulmerton Rd., Clearwater, Florida 33760
(Address of principal executive offices) (Zip Code)
 
(800) 537-2790
Registrant's telephone number, including area code
 
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
 
 
 

 

 
Item 2.02
Results of Operations and Financial Condition
 
On August 5, 2014, Bovie Medical Corporation (the “Company”) issued a press release reporting on its results of operations for the second quarter ended June 30, 2014. A copy of that press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
 
Item 9.01
Financial Statements and Exhibits
(d)
Exhibit No.
 
Description
99.1
 
Press release dated August 5, 2014.
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Date:  August 7, 2014
 
BOVIE MEDICAL CORPORATION
 
       
   
By:    /s/ Peter L. Donato
 
   
              Peter L. Donato
 
   
 Chief Financial Officer
 
 
 

 
 
 
2